Multisystem and Autonomic Complications of NMD on Long-term NIV
NCT ID: NCT04100993
Last Updated: 2024-10-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
35 participants
OBSERVATIONAL
2019-10-25
2021-05-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Variability Analysis as a Predictor of Liberation From Mechanical Ventilation
NCT01140750
Study of Neural Inspiratory Time and Expiratory Delay in Patient and Health During Spontaneous Breathing and Ventilation
NCT02817035
Monitoring of Non-invasive Ventilation
NCT01845233
The Relationship Between Arterial Stiffness and Respiratory Failure in Motor Neurone Disease
NCT03444428
Home Versus Hospital Based NIV Care in MND
NCT06844370
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Previous studies largely in children and adolescents suggest individuals with NMD may develop problems of the autonomic nervous system (ANS), a network of nerves vital to controlling the body's short-term responses to internal and external stimuli. It is likely some complications of NMD are related to ANS abnormalities.
This will be an exploratory observational study using a cross-sectional design in which non-invasive tools will be used to evaluate autonomic function during wake and sleep. Individuals over 16 years of age with a confirmed NMD diagnosis will be recruited. Derived parameters of autonomic function including heart rate variability will be compared to values from an exploratory reference group of age- and sex-matched healthy adults. Autonomic function will also be correlated to measures of symptom burden, complications, quality of life and disease severity. Qualitative methods will be used to further evaluate the experience and perceptions of adults with NMD in making decisions about their personal and medical care, which become more complex with increasing age and disease severity.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patient group
60 participants ≥16 years of age with a confirmed diagnosis of a childhood-onset NMD
No intervention used
No intervention used
Exploratory reference group
20 healthy adults ≥16 years of age
No intervention used
No intervention used
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention used
No intervention used
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥16 years
* Confirmed diagnosis of childhood-onset NMD
* Able and willing to provide informed consent
* Requires non-invasive ventilation on an intermittent or continuous basis to manage respiratory failure
Reference group:
* Age ≥16 years
* No significant co-morbidities
* Not on any regular medications
* Able and willing to provide informed consent
Exclusion Criteria
* Clinical instability or acute deterioration requiring hospitalisation or changes to medication in the previous 4 weeks
* A female of child-bearing potential who is pregnant or intends to become pregnant during study involvement
16 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Royal Brompton & Harefield NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Anita K Simonds, MD MBBS
Role: PRINCIPAL_INVESTIGATOR
Royal Brompton & Harefield NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Brompton Hospital
London, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
266270
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.